CN Patent

CN101208093A — 吡唑-嘧啶衍生物在治疗疼痛中的用途

Assigned to AstraZeneca AB · Expires 2008-06-25 · 18y expired

What this patent protects

本发明涉及式(I)的吡唑－嘧啶在制备用于治疗或预防疼痛的药物中的用途，式(I)中，n＝0、1、2或3；以及含有它们的药物组合物以及它们的方法用途。

USPTO Abstract

本发明涉及式(I)的吡唑－嘧啶在制备用于治疗或预防疼痛的药物中的用途，式(I)中，n＝0、1、2或3；以及含有它们的药物组合物以及它们的方法用途。

Drugs covered by this patent

larotrectinib-sulfate (LAROTRECTINIB SULFATE)

Patent Metadata

Patent number: CN101208093A
Jurisdiction: CN
Classification: —
Expires: 2008-06-25
Drug substance claim: No
Drug product claim: No
Assignee: AstraZeneca AB
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.